Heather Raymon
SVP, Research and Development, Artiva Biotherapeutics, Inc.
Bought, 12 months
$0.0M
Sold, 12 months
$0.0M
Companies
1
Latest trade
May 19, 2026
Companies
Artiva Biotherapeutics, Inc.SVP, Research and Development −$0.0M
Trades
Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.